Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Cubist Pharmaceuticals demographics summary. Zippia estimates demographics and statistics for Cubist Pharmaceuticals by using a database of 30 million profiles. Our estimates are verified against BLS, Census, and current job openings data for accuracy. After extensive research and analysis, Zippia's data science team found that:
| Cubist Pharmaceuticals CEO | Michael Bonney |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company type | Public |
| Cubist Pharmaceuticals employees who are women | 48% |
| Cubist Pharmaceuticals executives who are women | 18% |
| Cubist Pharmaceuticals employees who are minorities | 40% |
| Cubist Pharmaceuticals executives who are minorities | 43% |
| Most common minority at Cubist Pharmaceuticals | Asian |
| Most common foreign language | Spanish |
Rate the Cubist Pharmaceuticals' inclusivity.
Do you work at Cubist Pharmaceuticals?
Does Cubist Pharmaceuticals actively promote diversity and inclusion?
| Gender | Percentages |
|---|---|
| Male | 63.6% |
| Female | 36.4% |
| Race | Percentages |
|---|---|
| White | 54.9% |
| Asian | 25.6% |
| Hispanic or Latino | 9.8% |
| Black or African American | 6.1% |
| Unknown | 3.7% |
| Employees age | Percentages |
|---|---|
| Less than 18 years | 0% |
| 18-20 years | 0% |
| 20-30 years | 100% |
| 30-40 years | 0% |
| 40+ years | 0% |
| Number or Years | Percentages |
|---|---|
| Less than one year | 30% |
| 1-2 years | 32% |
| 3-4 years | 9% |
| 5-7 years | 7% |
| 8-10 years | 9% |
| 11+ years | 12% |
| Salary range | Cubist Pharmaceuticals | |
|---|---|---|
| <$25k | 0 jobs | - |
| $25k-40k | 14 jobs | - |
| $40k-60k | 52 jobs | - |
| $60k-100k | 115 jobs | - |
| $100k-200k | 136 jobs | - |
| >$200k | 13 jobs | - |
Cubist Pharmaceuticals employees are most likely to be members of the Democratic Party. The largest donation made to a political party by a Cubist Pharmaceuticals employee was by Michael Bonney, who donated $7,600 to the Republican Party.
Cubist Pharmaceuticals employee political donations
| Name | Job title | Party | Donation |
|---|---|---|---|
| Michael Bonney | Chief Executive Officer | Republican Party | $7,600 |
| David McGirr | Executive | Republican Party | $7,500 |
| Carisa de Anda | Clinical Researcher | Democratic Party | $3,200 |
| Demian Vargas | Sales/Marketing | Democratic Party | $1,000 |
| Timothy Hunt | Senior Vice President | Republican Party | $1,000 |
| TIM Hunt | Communicator | Republican Party | $1,000 |
| Alison Bonney | Chief Executive Officer | Democratic Party | $1,000 |
| Bradley Prosek | Investor | Democratic Party | $950 |
| Eileen McIntyre | Investor | Democratic Party | $850 |
| Josh Leichter | Housing Counselor | Democratic Party | $750 |
Zippia gives an in-depth look into the details of Cubist Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Cubist Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Cubist Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Cubist Pharmaceuticals. The data presented on this page does not represent the view of Cubist Pharmaceuticals and its employees or that of Zippia.
Cubist Pharmaceuticals may also be known as or be related to Cubist Pharmaceuticals, Cubist Pharmaceuticals INC, Cubist Pharmaceuticals LLC, Cubist Pharmaceuticals, INC and Cubist Pharmaceuticals, Inc.